Arriving in the arena of excess body fat therapy, retatrutide represents a unique approach. Different from many available medications, retatrutide functions as a dual agonist, simultaneously targeting both GLP-like peptide-1 (GLP-1) and glucose-responsive insulinotropic polypeptide (GIP) sensors. The dual stimulation fosters several advantageous ef